Tewari AK - Search Results

1

Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.

Reva BA, Omelchenko T, Nair SS, Tewari AK. Reva BA, et al. Among authors: tewari ak. Urol Clin North Am. 2020 Nov;47(4S):e9-e16. doi: 10.1016/j.ucl.2020.10.004. Epub 2020 Dec 9. Urol Clin North Am. 2020. PMID: 33446324 Review.

2

Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer.

Yadav KK, Shameer K, Readhead B, Yadav SS, Li L, Kasarskis A, Tewari AK, Dudley JT. Yadav KK, et al. Among authors: tewari ak. Curr Pharm Des. 2016;22(34):5234-5248. doi: 10.2174/1381612822666160513145924. Curr Pharm Des. 2016. PMID: 27174811 Review.

3

Intratumor heterogeneity in prostate cancer.

Yadav SS, Stockert JA, Hackert V, Yadav KK, Tewari AK. Yadav SS, et al. Among authors: tewari ak. Urol Oncol. 2018 Aug;36(8):349-360. doi: 10.1016/j.urolonc.2018.05.008. Epub 2018 Jun 7. Urol Oncol. 2018. PMID: 29887240 Review.

4

Inflammation and Prostate Cancer.

Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Tewari AK, et al. Adv Exp Med Biol. 2018;1095:41-65. doi: 10.1007/978-3-319-95693-0_3. Adv Exp Med Biol. 2018. PMID: 30229548 Review.

5

Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.

Beksac AT, Cumarasamy S, Falagario U, Xu P, Takhar M, Alshalalfa M, Gupta A, Prasad S, Martini A, Thulasidass H, Rai R, Berger M, Hectors S, Jordan J, Davicioni E, Nair S, Haines K 3rd, Lewis S, Rastinehad A, Yadav K, Jayaratna I, Taouli B, Tewari A. Beksac AT, et al. J Urol. 2018 Dec;200(6):1241-1249. doi: 10.1016/j.juro.2018.06.041. Epub 2018 Jul 3. J Urol. 2018. PMID: 30563651

6

A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome.

Martini A, Wang J, Brown NM, Cumarasamy S, Sfakianos JP, Rastinehad AR, Haines KG 3rd, Wiklund NP, Nair SS, Tewari AK. Martini A, et al. Among authors: tewari ak. BJU Int. 2019 Jul;124(1):155-162. doi: 10.1111/bju.14740. Epub 2019 Apr 3. BJU Int. 2019. PMID: 30825357

7

Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response.

Domankevich V, Cohen A, Efrati M, Schmidt M, Rammensee HG, Nair SS, Tewari A, Kelson I, Keisari Y. Domankevich V, et al. Cancer Immunol Immunother. 2019 Dec;68(12):1949-1958. doi: 10.1007/s00262-019-02418-5. Epub 2019 Oct 22. Cancer Immunol Immunother. 2019. PMID: 31637474 Free PMC article.

8

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.

Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, Mohamed N, Lundon D, Dovey Z, Kyprianou N, Tewari AK. Chakravarty D, et al. Among authors: tewari ak. Commun Biol. 2020 Jul 8;3(1):374. doi: 10.1038/s42003-020-1088-9. Commun Biol. 2020. PMID: 32641750 Free PMC article. Review.

9

Pseudouridine as a novel biomarker in prostate cancer.

Stockert JA, Weil R, Yadav KK, Kyprianou N, Tewari AK. Stockert JA, et al. Among authors: tewari ak. Urol Oncol. 2021 Jan;39(1):63-71. doi: 10.1016/j.urolonc.2020.06.026. Epub 2020 Jul 22. Urol Oncol. 2021. PMID: 32712138 Free PMC article. Review.

10

Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options.

Chakravarty D, Huang L, Kahn M, Tewari AK. Chakravarty D, et al. Among authors: tewari ak. Urol Clin North Am. 2020 Nov;47(4):487-510. doi: 10.1016/j.ucl.2020.07.010. Epub 2020 Sep 28. Urol Clin North Am. 2020. PMID: 33008499 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page